Physician profile
Armando Sardi
NPI 1679511570
$2,353.15
in general payments reported to CMS, 2019-2025
28 companies · $353 in 2025
The $353 reported for 2025 was more than what a typical Surgical Oncology provider received nationally (typical 2025 total: $288).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $329 · 2020: $41.25 · 2021: $247 · 2022: $449 · 2023: $452 · 2024: $482 · 2025: $353.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,287.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,287.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $647.44 | 2021-2025 | Enseal, Echelon Flex, Enseal X1 |
| Eisai INC. | $188.94 | 2019-2024 | |
| Springworks Therapeutics, INC. | $164.01 | 2024-2025 | Ogsiveo |
| Novartis Pharmaceuticals Corporation | $130.12 | 2019-2025 | |
| Baxter Healthcare | $122.79 | 2022-2024 | Perclot |
| Abbvie INC. | $108.73 | 2021-2025 | |
| Medtronic, INC. | $106.06 | 2023-2024 | Signia, Ligasure |
| Regeneron Healthcare Solutions, INC. | $103.68 | 2022-2025 | Libtayo |
| E.R. Squibb & Sons, L.L.C. | $87.91 | 2022-2023 | Opdualag |
| Pharmacyclics LLC, An Abbvie Company | $84.92 | 2022-2023 | Imbruvica |
| Hologic Sales and Service, LLC | $73.71 | 2022-2024 | Coolseal Generator |
| Merck Sharp & Dohme LLC | $58.30 | 2019-2021 | |
| Genzyme Corporation | $46.12 | 2021 | |
| Emd Serono, INC. | $44.34 | 2019 | |
| Angiodynamics, INC. | $43.27 | 2019-2020 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Covidien LP | $42.74 | 2019 | |
| Foundation Medicine, INC. | $35.44 | 2019-2023 | Foundationone Cdx |
| Integra Lifesciences Corporation | $33.76 | 2022 | |
| Kerecis Limited | $28.73 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Tempus Ai, INC | $28.14 | 2024 | Xt Cdx |
| C. R. Bard, INC. & Subsidiaries | $27.29 | 2023 | Arista Ah Flexitip |
| Nestle Healthcare Nutrition INC. | $25.68 | 2022 | |
| Avanos Medical | $22.11 | 2019 | |
| Abbott Laboratories | $21.58 | 2021 | |
| Tei Biosciences INC | $20.94 | 2019 | |
| Getinge USA Sales, LLC | $20.75 | 2025 | Maquet Powerled II |
| Shire North American Group INC | $18.34 | 2019 | |
| Surgical Specialties Corporation (US), INC. (Dba Corza Medical) | $17.31 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Armando Sardi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.